Synopsis
Motivation:
Goals:
Approach:
Results:
370-01-002
ISMRM Abstract
Quantitative T1/PD² Ratio to Differentiate Demyelination and Remyelination in Multiple Sclerosis
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Woo MS, Engler JB, Friese MA. The neuropathobiology of multiple sclerosis. Nat Rev Neurosci. 2024;25(7):493-513. doi:10.1038/s41583-024-00823-z [doi]
2. Kamma E, Lasisi W, Libner C, Ng HS, Plemel JR. Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics. J Neuroinflammation. 2022;19(1):45. doi: 10.1186/s12974-022-02408-y [doi]
3. Navas CT-D, Carlos A.; Munoz-Ceron, Joe; Álvarez, Carlos A.; García, Juan R.; Zarco, Luis; Vélez, Lázaro A.; Awad, Carlos; Castro, Carlos Alberto. Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. Multiple Sclerosis Journal—Experimental, Translational and Clinical. 2018;4(January-March):1-8. doi: https://doi.org/10.1177/2055217317752202 [doi]
4. Bagnato F, Sati P, Hemond CC, et al. Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain. 2024;147(9):2913-2933. doi: 10.1093/brain/awae013 [doi]
5. Podbielska M, Banik NL, Kurowska E, Hogan EL. Myelin recovery in multiple sclerosis: the challenge of remyelination. Brain Sci. 2013;3(3):1282-1324. doi: 10.3390/brainsci3031282 [doi]
6. Amann M, Papadopoulou A, Andelova M, et al. Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis. J Neurol. 2015;262(8):1909-1917. doi: 10.1007/s00415-015-7793-5 [doi]
7. Schlaeger S, Muhlau M, Gilbert G, et al. Sensitivity of multi-parametric quantitative magnetic resonance imaging for multiple sclerosis pathology. PLoS One. 2025;20(4):e0318415. doi: 10.1371/journal.pone.0318415 [doi]
8. Wisnieff C, Ramanan S, Olesik J, Gauthier S, Wang Y, Pitt D. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron. Magn Reson Med. 2015;74(2):564-570. doi: 10.1002/mrm.25420 [doi]
9. Haacke, E.; Subramanian, K.; Utriainen, D.; Palutla, V.K.; Yerramsetty, K.; Kumar, P.; Sethi, S.K.; Chen, Y.; Latif, Z.; et al. A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design. Diagnostics. 2022;12(1):77. doi: https://doi.org/10.3390/diagnostics12010077 [doi]
10. Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in MS. J Neurol. 2002;249(9):1279-1286. doi: 10.1007/s00415-002-0837-7 [doi]
11. Thaler C, Faizy TD, Sedlacik J, et al. T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis. AJNR Am J Neuroradiol. 2017;38(2):264-269. doi: 10.3174/ajnr.A5004 [doi]
12. Kolb H, Absinta M, Beck ES, et al. 7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions. Ann Neurol. 2021;90(4):612-626. doi: 10.1002/ana.26194 [doi]
13. Chen Y, Liu S, Wang Y, Kang Y, Haacke EM. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping. Magnetic Resonance Imaging. 2018;46:130-139. doi: 10.1016/j.mri.2017.10.005 [doi]
14. Wang Y, Chen Y, Wu D, et al. STrategically Acquired Gradient Echo (STAGE) imaging, part II: Correcting for RF inhomogeneities in estimating T1 and proton density. Magn Reson Imaging. 2018;46:140-150. doi: 10.1016/j.mri.2017.10.006 [doi]
15. Helms G, Dathe H, Kallenberg K, Dechent P. High-resolution maps of magnetization transfer with inherent correction for RF inhomogeneity and T1 relaxation obtained from 3D FLASH MRI. Magn Reson Med. 2008;60(6):1396-1407. doi: 10.1002/mrm.21732 [doi]
16. Rahmanzadeh R, Weigel M, Lu PJ, et al. A comparative assessment of myelin-sensitive measures in multiple sclerosis patients and healthy subjects. Neuroimage Clin. 2022;36:103177. doi: 10.1016/j.nicl.2022.103177 [doi]
17. Haacke EM, Xu Q, Kokeny P, et al. Strategically Acquired Gradient Echo (STAGE) Imaging, part IV: Constrained Reconstruction of White Noise (CROWN) Processing as a Means to Improve Signal-to-Noise in STAGE Imaging at 3 Tesla. Magn Reson Imaging. 2024;107:55-68. doi: 10.1016/j.mri.2019.09.006 [doi]
18. Mansfield P. NMR Imaging in Biomedicine: Supplement 2 Advances in Magnetic Resonance. London, England: Academic Press 1982.
19. Kiricuta I-CJS, Virgil. Tissue Water Content and Nuclear Magnetic Resonance in Normal and Tumor Tissues. Cancer Research. 1975;35(5):1164-1167.
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/370-01-002